ProKidney Corp.
PROK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $76 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $76 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $127,668 | $106,707 | $82,070 | $46,255 |
| G&A Expenses | $56,084 | $44,815 | $70,937 | $8,855 |
| SG&A Expenses | $56,084 | $44,815 | $70,937 | $8,855 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $183,752 | $151,522 | $153,007 | $55,110 |
| Operating Income | -$183,676 | -$151,522 | -$153,007 | -$55,110 |
| % Margin | -241,678.9% | – | – | – |
| Other Income/Exp. Net | $19,743 | $22,071 | $5,768 | $2 |
| Pre-Tax Income | -$163,933 | -$129,451 | -$147,239 | -$55,108 |
| Tax Expense | -$598 | $5,996 | $896 | $38 |
| Net Income | -$61,186 | -$35,468 | -$108,032 | -$55,146 |
| % Margin | -80,507.9% | – | – | – |
| EPS | -0.62 | -0.57 | -1.76 | -1.73 |
| % Growth | -8.8% | 67.6% | -1.7% | – |
| EPS Diluted | -0.62 | -0.57 | -1.76 | -1.73 |
| Weighted Avg Shares Out | 97,916 | 61,714 | 61,540 | 31,890 |
| Weighted Avg Shares Out Dil | 97,916 | 61,714 | 61,540 | 31,890 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19,752 | $22,083 | $5,983 | $2 |
| Interest Expense | $9 | $12 | $215 | $0 |
| Depreciation & Amortization | $5,432 | $3,853 | $3,036 | $1,984 |
| EBITDA | -$158,492 | -$125,586 | -$143,988 | -$53,124 |
| % Margin | -208,542.1% | – | – | – |